SMAD2 and colorectal carcinoma: Our results clearly show that Calebin A reversed TME-induced changes in the expression of TGF-β1, p-Smad-2, and EMT biomarkers, similar to CD, in a concentration-dependent manner, suggesting that TME-stimulated EMT can be attenuated in CRC cells.